WallStreetZenWallStreetZen

NASDAQ: MXCT
Maxcyte Inc Stock Ownership - Who owns Maxcyte?

Insider buying vs selling

Have Maxcyte Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
John Joseph JohnstonDirector2024-03-265,000$2.14
$10.71kBuy
John Joseph JohnstonDirector2024-03-265,000$4.41
$22.03kSell
John Joseph JohnstonDirector2024-02-265,000$4.60
$23.01kSell
John Joseph JohnstonDirector2024-02-265,000$2.14
$10.71kBuy
John Joseph JohnstonDirector2024-01-265,000$2.14
$10.71kBuy
John Joseph JohnstonDirector2024-01-265,000$5.12
$25.59kSell
John Joseph JohnstonDirector2023-12-265,000$2.14
$10.71kBuy
John Joseph JohnstonDirector2023-12-265,000$4.53
$22.65kSell
Douglas DoerflerPresident and CEO2023-12-0599,442$5.17
$514.12kSell
Douglas DoerflerPresident and CEO2023-12-0599,442$0.04
$3.98kBuy

1 of 5

MXCT insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MXCT insiders and whales buy or sell their stock.

MXCT Shareholders

What type of owners hold Maxcyte Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Casdin Partners Master Fund LP9.60%10,000,000$37.40MInsider
Blackrock Inc7.05%7,341,386$27.46MInstitution
Cadian Capital Management LP5.42%5,644,898$21.11MInstitution
Vanguard Group Inc5.07%5,282,108$19.76MInstitution
Vitruvian Partners LLP4.84%5,043,356$18.86MInstitution
Millennium Management LLC4.81%5,012,283$18.75MInstitution
Morgan Stanley3.34%3,481,010$13.02MInstitution
Fmr LLC2.72%2,833,715$10.60MInstitution
Portolan Capital Management LLC2.65%2,757,249$10.31MInstitution
Massachusetts Financial Services Co2.44%2,537,114$9.49MInstitution

1 of 3

MXCT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MXCT62.67%11.15%Net BuyingNet Buying
ANIK84.64%15.36%Net SellingNet Selling
SRDX62.61%37.39%Net SellingNet Buying
PACB92.99%7.01%Net BuyingNet Buying
NPCE29.97%70.03%Net SellingNet Selling

Maxcyte Stock Ownership FAQ

Who owns Maxcyte?

Maxcyte (NASDAQ: MXCT) is owned by 62.67% institutional shareholders, 11.15% Maxcyte insiders, and 26.17% retail investors. Casdin Partners Master Fund LP is the largest individual Maxcyte shareholder, owning 10.00M shares representing 9.60% of the company. Casdin Partners Master Fund LP's Maxcyte shares are currently valued at $36.90M.

If you're new to stock investing, here's how to buy Maxcyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.